Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Chemotherapy Companies

Chemotherapy companies play a crucial role in the development, manufacturing, and distribution of chemotherapy drugs, which are used to treat various types of cancer. Chemotherapy involves the use of powerful medications to inhibit or kill cancer cells.

*Disclaimer: List of key companies in no particular orderLatest Chemotherapy Companies Update

Oct 2023: Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are less than expected and cut revenue expectations for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. The company said that global usage of Paxlovid is trending slightly above last year but still below expectations. The fall vaccination period just began, and the New York City drugmaker said it is too soon to get a handle on year-round vaccination rates. That number also accounts for delayed product commercialization, pushed to January 2024 from the company’s previous expectation of commercialization in the second half of this year.

June 2023: The US Food and Drug Administration has acknowledged and granted Priority Review to AstraZeneca's supplemental New Drug Application (sNDA) for TAGRISSO® (osimertinib) used together with chemotherapy for the medical management of adult patients with advanced locally or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). Applications for drugs that, if approved, would provide significant enhancements over current choices by demonstrating safety or efficacy enhancements, preventing serious illnesses, or improving patient compliance are given Priority Review by the Food and Drug Administration (FDA). Importantly, individuals with central nervous system metastases were included in the subgroups that showed a clinically significant PFS advantage.

List of Chemotherapy Key companies in the market

Johnson & Johnson Services Inc (US)

GlaxoSmithKline PLC (UK)

Eli Lilly and Company (US)

F. Hoffmann-La Roche Ltd (Switzerland)

Novartis AG (Switzerland)

Pfizer Inc. (US)

Merck & Co. Inc. (US)

Sanofi S.A. (France)

Celgene Corporation (US)

Bristol-Myers Squibb

Chemotherapy Market Highlights:

Chemotherapy Market Size

Chemotherapy Market Trends

Chemotherapy Market Analysis

Chemotherapy Market Share

Chemotherapy Market Highlights:

Chemotherapy Market Trends

Chemotherapy Market Analysis

Chemotherapy Market Share

Chemotherapy Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.